High prevalence and functional impairment make anxiety disorders a major concern in psychiatric care. With anxiety disorders: advances in therapy and research, new pathways are being explored beyond conventional exposure-based treatments. Advances in neurobiology have revealed how fear circuitry and stress responses can be modulated through therapies such as mindfulness-based interventions, EMDR, and even psychedelic-assisted therapy. Emerging pharmacologic agents offer rapid symptom relief with fewer side effects. Technological tools like virtual reality are enhancing the delivery of exposure therapy, especially for social and phobic anxiety. Combining neuroscience, psychotherapy, and tech-based delivery systems fosters earlier intervention, higher engagement, and sustained treatment outcomes.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States